CD47 and cancer: Lung cancer cells and macrophages seem to be able to establish an interaction similar to that of PD-1–PD-L1, meaning that malignant cells in small cell lung cancer express the CD47 antigen when they bind to the SIRPα receptor, leading to the macrophage loss of capability to phagocyte the cancer cells.